NAYA Therapeutics

NAYA Therapeutics es una empresa biotecnológica en fase clínica que desarrolla anticuerpos bifuncionales de nueva generación contra el cáncer. Su plataforma patentada, lista para usar, mejora la formación de sinapsis inmunitarias para la destrucción precisa de tumores. Con programas líderes en CHC y mieloma múltiple, NAYA está desarrollando una línea de productos diferenciada que incluye NY-303 (GPC3 x NKp46), NY-500 (PD-1 x...

País

United States

Sitio web

nayatx.com

Fundado

2023

Sociales

Fuente de información:

https://www.nayatx.com/

Añadir a mi lista

Ejecutivos clave

Daniel Teper

Founder and CEO

Michael G. King

Executive Vice President

Lyn Falconio

CCO

Industrias

Disclaimer

The content of this website is not directed at or intended for persons in the United Kingdom or any other jurisdiction where the provision of the website or services would breach any applicable law or registration or would require any registration or license in any such jurisdiction. The content of this website should not be regarded as an invitation or inducement to engage in investment activity, to any person in the United Kingdom and investment opportunities described on this website are not intended to be acted upon by any persons in the United Kingdom.